2.8776
price down icon2.60%   -0.0767
after-market Dopo l'orario di chiusura: 2.89 0.0124 +0.43%
loading
Precedente Chiudi:
$2.9543
Aprire:
$3.1942
Volume 24 ore:
3,155
Relative Volume:
0.47
Capitalizzazione di mercato:
$4.30M
Reddito:
$5.67M
Utile/perdita netta:
$-13.98M
Rapporto P/E:
-0.2037
EPS:
-14.13
Flusso di cassa netto:
$-15.30M
1 W Prestazione:
-8.65%
1M Prestazione:
-8.65%
6M Prestazione:
-16.71%
1 anno Prestazione:
+39.69%
Intervallo 1D:
Value
$2.8655
$3.1942
Intervallo di 1 settimana:
Value
$2.74
$3.20
Portata 52W:
Value
$1.9001
$10.31

Arcadia Biosciences Inc Stock (RKDA) Company Profile

Name
Nome
Arcadia Biosciences Inc
Name
Telefono
530-756-7077
Name
Indirizzo
202 COUSTEAU PLACE, DAVIS, CA
Name
Dipendente
9
Name
Cinguettio
@ArcadiaAg
Name
Prossima data di guadagno
2024-11-12
Name
Ultimi documenti SEC
Name
RKDA's Discussions on Twitter

Confronta RKDA con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Packaged Foods icon
RKDA
Arcadia Biosciences Inc
2.8776 4.30M 5.67M -13.98M -15.30M -14.13
Packaged Foods icon
KHC
Kraft Heinz Co
29.94 36.36B 25.85B 2.74B 3.02B 2.26
Packaged Foods icon
GIS
General Mills Inc
57.67 32.31B 19.64B 2.56B 2.48B 4.55
Packaged Foods icon
K
Kellanova
82.41 28.46B 12.75B 1.34B 1.13B 3.87
Packaged Foods icon
MKC
Mccormick Co Inc
74.67 20.81B 6.68B 792.60M 774.40M 2.94
Packaged Foods icon
HRL
Hormel Foods Corp
30.40 16.80B 11.92B 805.04M 1.01B 1.46

Arcadia Biosciences Inc Stock (RKDA) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2020-08-17 Reiterato H.C. Wainwright Buy
2017-05-12 Downgrade Piper Jaffray Overweight → Neutral
2015-06-09 Iniziato Credit Suisse Outperform
2015-06-09 Iniziato Piper Jaffray Overweight

Arcadia Biosciences Inc Borsa (RKDA) Ultime notizie

pulisher
Apr 16, 2025

Arcadia Biosciences (NASDAQ:RKDA) Now Covered by StockNews.com - Defense World

Apr 16, 2025
pulisher
Apr 09, 2025

Arcadia Biosciences (NASDAQ:RKDA) Coverage Initiated by Analysts at StockNews.com - The AM Reporter

Apr 09, 2025
pulisher
Apr 03, 2025

Arcadia Biosciences regains IP rights, amends agreement - Investing.com

Apr 03, 2025
pulisher
Apr 03, 2025

Arcadia Biosciences IncEnters Agreement To Transfer Patents And Rights With A Third Party- SEC Filing - MarketScreener

Apr 03, 2025
pulisher
Apr 03, 2025

Arcadia Biosciences regains IP rights, amends agreement By Investing.com - Investing.com UK

Apr 03, 2025
pulisher
Apr 01, 2025

Head-To-Head Contrast: Lendway (NASDAQ:LDWY) versus Arcadia Biosciences (NASDAQ:RKDA) - The AM Reporter

Apr 01, 2025
pulisher
Apr 01, 2025

Arcadia Biosciences (NASDAQ:RKDA) vs. Lendway (NASDAQ:LDWY) Critical Analysis - Defense World

Apr 01, 2025
pulisher
Mar 25, 2025

Arcadia Biosciences Inc. (RKDA) reports earnings - qz.com

Mar 25, 2025
pulisher
Mar 23, 2025

Arcadia Biosciences outlines 2025 growth potential for Zola after 46% sales increase in 2024 - MSN

Mar 23, 2025
pulisher
Mar 23, 2025

Arcadia Biosciences (NASDAQ:RKDA) Now Covered by Analysts at StockNews.com - Defense World

Mar 23, 2025
pulisher
Mar 22, 2025

Arcadia Biosciences, Inc. (NASDAQ:RKDA) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 22, 2025
pulisher
Mar 22, 2025

Arcadia Biosciences CEO Thomas Schaefer buys $1,743 in stock - MSN

Mar 22, 2025
pulisher
Mar 21, 2025

Arcadia Biosciences Earnings Call Highlights Zola Growth - TipRanks

Mar 21, 2025
pulisher
Mar 21, 2025

Arcadia Biosciences Inc (RKDA) Q4 2024 Earnings Report Preview: What To Look For - GuruFocus.com

Mar 21, 2025
pulisher
Mar 21, 2025

Arcadia Biosciences Inc (RKDA) Q4 2024 Earnings Call Highlights: Strong Zola Sales Propel ... - Yahoo Finance

Mar 21, 2025
pulisher
Mar 21, 2025

Arcadia Biosciences Reports Strong Revenue Growth in 2024 - TipRanks

Mar 21, 2025
pulisher
Mar 20, 2025

Earnings call transcript: Arcadia Biosciences Q4 2024 sees revenue growth By Investing.com - Investing.com Canada

Mar 20, 2025
pulisher
Mar 20, 2025

Arcadia Biosciences Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits - Quantisnow

Mar 20, 2025
pulisher
Mar 20, 2025

Arcadia Biosciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 20, 2025
pulisher
Mar 20, 2025

Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2024 Financial Results and Business Highlights - Quantisnow

Mar 20, 2025
pulisher
Mar 20, 2025

Arcadia Biosciences (RKDA) Expected to Announce Earnings on Thursday - Defense World

Mar 20, 2025
pulisher
Mar 20, 2025

Arcadia Biosciences Crushes Q4 Expectations: 124% Growth in Zola Brand Powers Record Revenue - Stock Titan

Mar 20, 2025
pulisher
Mar 18, 2025

Arcadia Biosciences Inc expected to post a loss of 89 cents a shareEarnings Preview - TradingView

Mar 18, 2025
pulisher
Mar 07, 2025

Arcadia Biosciences, Inc. to Host Earnings Call - ACCESS Newswire

Mar 07, 2025
pulisher
Mar 07, 2025

StockNews.com Initiates Coverage on Arcadia Biosciences (NASDAQ:RKDA) - The AM Reporter

Mar 07, 2025
pulisher
Mar 06, 2025

Arcadia Biosciences (RKDA) Announces Date of Fourth Quarter 2024 Financial Results and Business Highlights Conference Call - Business Wire

Mar 06, 2025
pulisher
Feb 27, 2025

Arcadia Biosciences (NASDAQ:RKDA) Earns Sell Rating from Analysts at StockNews.com - Defense World

Feb 27, 2025
pulisher
Feb 24, 2025

RKDA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Arcadia Biosciences, Inc. is Fair to Shareholders - Business Wire

Feb 24, 2025
pulisher
Feb 17, 2025

Arcadia Biosciences CFO Kawakami buys $1,743 in stock - MSN

Feb 17, 2025
pulisher
Feb 16, 2025

$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The MergerEVGR, QTRX, RKDA, EBTC - The Malaysian Reserve

Feb 16, 2025
pulisher
Feb 14, 2025

$TOCKHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger – EVGR, QTRX, RKDA, EBTC - GlobeNewswire Inc.

Feb 14, 2025
pulisher
Feb 06, 2025

Arcadia Biosciences CEO Thomas Schaefer buys $1,743 in stock By Investing.com - Investing.com South Africa

Feb 06, 2025
pulisher
Feb 05, 2025

Arcadia Biosciences CFO Kawakami buys $1,743 in stock By Investing.com - Investing.com Canada

Feb 05, 2025
pulisher
Feb 05, 2025

Chief Financial Officer Kawakami Mark bought $1,743 worth of shares (700 units at $2.49), increasing direct ownership by 35% to 2,681 units (SEC Form 4) - Quantisnow

Feb 05, 2025
pulisher
Feb 05, 2025

Chief Executive Officer Schaefer Thomas J. bought $1,743 worth of shares (700 units at $2.49), increasing direct ownership by 33% to 2,819 units (SEC Form 4) - Quantisnow

Feb 05, 2025
pulisher
Jan 29, 2025

StockNews.com Begins Coverage on Arcadia Biosciences (NASDAQ:RKDA) - Armenian Reporter

Jan 29, 2025
pulisher
Jan 18, 2025

Arcadia Biosciences (NASDAQ:RKDA) Coverage Initiated at StockNews.com - Defense World

Jan 18, 2025

Arcadia Biosciences Inc Azioni (RKDA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Arcadia Biosciences Inc Azioni (RKDA) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Schaefer Thomas J.
Chief Executive Officer
Feb 03 '25
Buy
2.49
700
1,743
2,819
Kawakami Mark
Chief Financial Officer
Aug 01 '24
Buy
2.06
700
1,442
1,981
Schaefer Thomas J.
Chief Executive Officer
Aug 01 '24
Buy
2.06
700
1,442
2,119
$72.96
price down icon 2.88%
packaged_foods CPB
$37.57
price up icon 0.11%
packaged_foods SJM
$115.90
price down icon 0.46%
packaged_foods PPC
$53.64
price down icon 0.69%
packaged_foods CAG
$25.39
price up icon 0.24%
packaged_foods HRL
$30.40
price down icon 0.59%
Capitalizzazione:     |  Volume (24 ore):